Oncolytic action of prostaglandins.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D001551:Benz(a)Anthracenes; D003338:Corpus Luteum / Q000187:drug effects; D046508:Culture Techniques; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology; D009369:Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D011555:Pseudopregnancy; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D013997:Time Factors; D014316:Tritium; D014599:Uterus / Q000187:drug effects
D001551:Benz(a)Anthracenes; D004967:Estrogens; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D014316:Tritium